Cibus (CBUS) Enterprise Value (2016 - 2026)
Cibus (CBUS) posted Enterprise Value of -$9.9 million for Q4 2025, up 58.48% sequentially from -$23.9 million in Q3 2025, and down 13.29% YoY from -$11.4 million in Q4 2024.
Cibus (CBUS) Enterprise Value (2016 - 2026) Analysis & Trends
Cibus has reported Enterprise Value for 10 years, with the latest figure at -$9.9 million in Q4 2025.
- Quarterly Enterprise Value fell 13.29% year-over-year to -$9.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.9 million (down 13.29% YoY) and the FY2025 annual result came in at -$9.9 million, down 13.29% from the prior year.
- Enterprise Value advanced to -$9.9 million in Q4 2025 per CBUS's latest filing, from -$23.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at $97.2 million in Q3 2023 and troughed at -$34.1 million in Q2 2025.
- A 5-year average of -$116500.0 and a median of -$10.9 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value soared 1449.35% in 2023, then tumbled 619.58% in 2025.
- Over 5 years, Enterprise Value stood at -$14.3 million in 2021, then jumped by 75.38% to -$3.5 million in 2022, then surged by 443.87% to $12.1 million in 2023, then sank by 172.24% to -$8.8 million in 2024, then retreated by 13.29% to -$9.9 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$9.9 million, -$23.9 million, and -$34.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | -20.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.43 Mn |
| Dec 31, 2025 | -9.92 Mn |
| Sep 30, 2025 | -23.90 Mn |
| Jun 30, 2025 | -34.15 Mn |
| Mar 31, 2025 | -23.59 Mn |
| Dec 31, 2024 | -8.76 Mn |
| Sep 30, 2024 | -16.06 Mn |
| Jun 30, 2024 | 6.57 Mn |
| Mar 31, 2024 | 17.10 Mn |
| Dec 31, 2023 | 12.13 Mn |
| Sep 30, 2023 | 97.22 Mn |
| Jun 30, 2023 | 85.97 Mn |
| Mar 31, 2023 | -2.05 Mn |
| Dec 31, 2022 | -3.53 Mn |
| Sep 30, 2022 | -7.21 Mn |
| Jun 30, 2022 | -11.86 Mn |
| Mar 31, 2022 | -17.78 Mn |
| Dec 31, 2021 | -14.32 Mn |
| Sep 30, 2021 | -13.92 Mn |
| Jun 30, 2021 | -17.49 Mn |